Zacks Investment Management’s Edwards Lifesciences EW Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	–	Sell	-2,577	Closed	-$243K	–	643
2023 Q2	$243K	Buy	2,577 +64	+3%	+$5.56K	﹤0.01%	568
2023 Q1	$208K	Sell	2,513 -171	-6%	-$13.4K	﹤0.01%	583
2022 Q4	$200K	Sell	2,684 -494	-16%	-$38.1K	﹤0.01%	568
2022 Q3	$263K	Sell	3,178 -129,165	-98%	-$12.4M	﹤0.01%	503
2022 Q2	$12.6M	Buy	132,343 +6,354	+5%	+$658K	0.19%	117
2022 Q1	$14.8M	Buy	125,989 +464	+0.4%	+$52.1K	0.21%	116
2021 Q4	$16.3M	Buy	125,525 +4,598	+4%	+$536K	0.23%	108
2021 Q3	$13.7M	Buy	120,927 +2,024	+2%	+$231K	0.22%	110
2021 Q2	$12.3M	Buy	118,903 +7,097	+6%	+$669K	0.2%	117
2021 Q1	$9.35M	Sell	111,806 -2,077	-2%	-$176K	0.17%	125
2020 Q4	$10.4M	Sell	113,883 -34,733	-23%	-$2.88M	0.19%	116
2020 Q3	$11.9M	Sell	148,616 -39,020	-21%	-$3.04M	0.24%	106
2020 Q2	$13M	Buy	187,636 +6,160	+3%	+$438K	0.29%	85
2020 Q1	$11.4M	Buy	181,476 +31,839	+21%	+$2.3M	0.28%	88
2019 Q4	$11.6M	Sell	149,637 -1,401	-0.9%	-$109K	0.22%	100
2019 Q3	$11.1M	Buy	151,038 +2,742	+2%	+$193K	0.22%	99
2019 Q2	$9.13M	Buy	148,296 +2,982	+2%	+$180K	0.19%	108
2019 Q1	$9.27M	Sell	145,314 -4,236	-3%	-$242K	0.2%	106
2018 Q4	$7.64M	Buy	149,550 +5,865	+4%	+$297K	0.18%	109
2018 Q3	$8.34M	Sell	143,685 -53,241	-27%	-$2.6M	0.17%	112
2018 Q2	$9.55M	Buy	196,926 +921	+0.5%	+$43K	0.21%	104
2018 Q1	$9.12M	Buy	196,005 +5,508	+3%	+$239K	0.2%	107
2017 Q4	$7.16M	Sell	190,497 -9,744	-5%	-$358K	0.16%	119
2017 Q3	$7.3M	Buy	200,241 +87,714	+78%	+$3.35M	0.17%	119
2017 Q2	$4.43M	Buy	+112,527	New	+$4.11M	0.11%	148
2015 Q2	–	Sell	-69,918	Closed	-$1.66M	–	651
2015 Q1	$1.66M	Sell	69,918 -41,196	-37%	-$924K	0.05%	203
2014 Q4	$2.36M	Buy	+111,114	New	+$2.23M	0.08%	175